ArticleEuropean radiology experimental2026
Combining DMI and [
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The unique capability of deuterium metabolic imaging (DMI) to detect downstream metabolic products and trace substrates' transport within tissues using conventional magnetic resonance (MR) scanners can, in theory, be employed with routine positron emission tomography (PET)/MR equipment. Our technical proof-of-concept study proposes a protocol for the simultaneous acquisition of DMI and [¹⁸F]FDG-PET data to enable dual assessment of hepatic glucose metabolism. A protocol that integrates high-dose glucose administration, required for DMI, with [¹⁸F]FDG-PET imaging was applied in a spectroscopy-validated rodent model of metabolic dysfunction-associated fatty liver disease (MAFLD). We acquired and quantified high-quality DMI and PET data of the liver that could provide a distinction between healthy and MAFLD cohorts in the future. RELEVANCE STATEMENT: This proof-of-concept study demonstrates the simultaneous DMI-[
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.